Recent studies examining MR function in various vascular beds in experimental models with endothelial dysfunction, hypertension and/or high circulating aldosterone concentrations, clearly suggest that not all vascular beds show altered vessel contractility in response to deletion of the EC MR [21–23]. The gene discussed is NR3C2; the disease is hypertensive disorder.